UniHealth

06/08/2025

🌍 On 20 May 2025, the World Health Assembly adopted the Agreement – a historic step to strengthen global pandemic , , and response.

➡️ A new Intergovernmental Working Group ( ) will now lead the drafting of the Pathogen Access and Benefit-Sharing (PABS) Annex. This is a Milestone for Health Security and Global Pandemic Preparedness.
🎯 This also marks a major move toward international collaboration and stronger public health protection.

At UniHealth, we’re proud to support these global efforts, fostering collaboration and innovation to safeguard health worldwide.

This link will take you to a page that’s not on LinkedIn

24/07/2025

📢 🌍 New International Course Alert: Pandemic Centre, Universitetet i Bergen, through the direction of Prof. Esperanza Díaz Pérez, partner of UniHealth project, in partnership with Universidade Nova de Lisboa, Bielefeld University and Erasmus University Rotterdam are launching an exciting online course with a mobility option one week to , Norway.

⁉️ Are you prepared for the next health crises? Are you passionate about global health, crisis management, or interdisciplinary collaboration?
💡UniHealth supports the interdisciplinarity that can strengthen global health crisis preparedness. 🔗 Learn more and apply: https://bit.ly/4f5Eu81

🎓 Preparedness for Health Crises: A Multidisciplinary Approach
📅 Fall 2025
🌍 Online lectures afternoons twice a week for 6 weeks+ mobility option to
🌐 Open for all master and PhD students from Erasmus+ affiliated Universities to apply.
🎯 Exciting interdisciplinary lectures, expert guest speakers, digital trans-national and interdisciplinary group work (3/4 ECTS)

EExcited to announce an upcoming online course with mobility option

17/07/2025

📍 WP6 meeting 'Social insights into testing and pandemic preparedness' was held in Paris at the Institut Pasteur from 30th June to 4th July.

🧫 🔬 Prof. Tamara Giles-Vernick, Eleana D., Ana Lucia Estrada Jaramillo from the Institut Pasteur, and Prof. Esperanza Díaz Pérez, Prabhjot Kour, and Anders Kuvaas Herting from the Universitetet i Bergen met at the Institut Pasteur to discuss recent advancements in their research.

🧑‍⚕️ 👨‍🦽‍➡️ The main points of the discussions were the acceptance of testing and its implementation in pandemic preparedness, according to the perspectives of the public, healthcare workers, migrants, and older adults in France and Norway.

🏥 🩸 WP6 aims to build acceptance of diagnostic solutions employed at the and capitalize on results obtained from surveillance studies in 4 countries regarding end users’ expectations and accepted means of implementation of devices during a pandemic. This systematic study, addressing a broad group of potential users, will provide valuable input applicable to all diagnostic technologies prepared for application including but not limited to UniHealth project.

The partners identified several similar points between the two countries and outlined plans for future dialogues based on the results.

11/07/2025

👩‍⚕️ ✈️ Esperanza Díaz Pérez, Prof. in the Universitetet i Bergen, an indispensable UniHealth partner, travelled to Paris, with the Post- doctoral researcher Prabhjot Kour and the Ph.D. candidate Anders Kuvaas Herting to engage in discussions focusing on public and expert views regarding testing for future use.
⚕️ These novel tools are being developed during UniHealth, aiming to enable societies and developers to better address future pandemics with accepted solutions.

02/07/2025

✈️ 🤝 Biopix DNA Technology S.A. traveled to to meet Noklus team and provide training regarding the use of and , two point-of-care analysis instruments for the detection of various viruses. 👏
Noklus will evaluate the analytical quality and user-friendliness of these innovative technology, which will meet tomorrow's needs of a pandemic potential among humans and animals.

The aim is that these devices can be quickly reprogrammed to detect viruses in case of new future pandemics. Noklus will initially investigate the quality of these devices for detecting -19 and , thereby contributing the team's cutting-edge expertise in patient-centric analysis and performance studies to ensure the analytical quality and user-friendliness of the devices.

In addition of the training, Biopix DNA Technology S.A. team gave a lecture at the head office of Noklus, where they presented the company and their contribution to the UniHealth project.

📸 1st photo: Stella Chatziioannidou is providing training in the use of and . The employees of Noklus are watching closely.

📸 2nd photo (from the left): Emilie Kristine Nygaard, Sverre Sandberg, Stella Chatziioannidou, George Papadakis, Anne Stavelin, Gro Gidske, Eva Rønneseth, Christine Morken.

16/06/2025

📢 'MENA Region One Health' conference, was held in Tunis on 14–15 June 2025. The conference was hosted by the Government of Tunisia and co-organized by the World Bank and the Quadripartite Organizations: FAO, United Nations Environment Programme Finance Initiative (UNEP FI), World Health Organization, and the World Organization for Animal Health. This landmark event represented a major step forward in advancing the One Health approach across the region.

🤝 It brought together decision-makers, experts, and leaders to foster collaboration at the intersection of human, animal, and environmental health.

UniHealth partners from Institut Pasteur de Tunis - معهد باستور تونسProf. ALi BOUATTOUR and Youmna M'ghirbi are in the forefront of approach and participated in the conference and discussed the UniHealth progress.

Tunisia’s Health Minister, Mustapha Ferjani discussed how the ‘One Health’ agenda is key to MENA’s health transformation and how regional partnerships and integrated health strategies are playing a critical role in transforming public health systems across North Africa and the Eastern Mediterranean.

🏥 🦟 🪴 One Health is an integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals and ecosystems. 😷 The COVID-19 pandemic has highlighted the interconnectedness of human, animal and ecosystem health ­­— emphasizing the need for a One Health approach that addresses the interconnected risks and vulnerabilities of human, animal and ecosystem health.

10/06/2025

📢 UniHealth welcomes the historic decision taken by the World Health Organization during the 77th World Health Assembly: the adoption of a global agreement driven by the goal of making the world safer from – and more equitable in response to – future .

🤝 This is a strong validation of the UniHealth work and a powerful call to continue with our goal- contribute to global and for the next health crisis.

🏥 The agreement aligns closely with the European One Health vision that underpins the UniHealthUniHealth EU project and promotes a coordinated and equitable, preparedness approach.



https://www.who.int/news/item/20-05-2025-world-health-assembly-adopts-historic-pandemic-agreement-to-make-the-world-more-equitable-and-safer-from-future-pandemics

27/05/2025

🎯 HBio Cluster, the , & partner of UniHealth participated in the on May 5-6, 2025 in Basel, Switzerland.

🤝 It was a great opportunity to disseminate UniHealth EU project and meet with professionals, industry experts, research and be involved in cutting-edge discussions, networking opportunities, and insights into the latest advancements in Life Sciences. 🌍

🤝 Together, we can change the scene in detection and infectious diseases prevention.

27/05/2025

✨ UniHealth participates in the PREPARE-EU Spring school "Connecting European Expertise for " on 3-4 June 2025, in Leuven, Belgium. 13 EU projects will tackle this broad topic from very different angles with the intention to demonstrate European effort in fighting the old and new pandemics.

🥼 Anastasia Galanopoulou, Post-doctoral researcher from the Gizeli Biosensors Group will represent UniHealth during the session “Technological advancements to fight old and new ”.

➡️ Early-bird registration is still open: https://lnkd.in/djGy6VAb

This link will take you to a page that’s not on LinkedIn

29/04/2025

🎬 Action, rolling!
❓ Curious about how our partners are bringing their expertise together and what we've accomplished so far at UniHealth? Dive into the full series on our website to find out more! 🎤 📹 🔍

Stella Chatziioannidou, Head of Research and Development and Production at Biopix DNA Technology S.A., shared why their research in collaboration with Gizeli Biosensors Group is vital and how it could revolutionize the developments related to the production of novel in vitro molecular diagnostic devices. 🧬

Andrew De Pao, Chief Business Officer at Kiara Health (Pty) Ltd, discussed how they will oversee the new devices and associated reagents production and validation developed within the UniHealth project.

Ian Botha, Associate Researcher from the University College London Hospitals NHS Foundation Trust touched upon the project's clinical aspects - from the challenge of organizing and conducting validation studies of at the , to data management, surveillance and digital .

Dr. Aikaterini Zisaki, Quality Assurance Management Systems & Regulatory Affairs Specialist at PKNM Solutions Sàrl- offered exclusive insights into the EU regulatory landscape shaping our work ⚖️.

Sverre Sandberg, Head of Noklus discussed the pre- and post- market analytical performance for the novel devices and tests by healthcare providers and lay persons, as well as the evaluation of the quality and the user friendliness.

Esperanza Díaz Pérez, Director of the Pandemic Centre, UiB and Prof. at the Universitetet i Bergen touched upon the project’s social aspects and discussed the public and experts’ perspectives on testing in the future deployment of our novel tools.

Youmna M'ghirbi, Associate Prof. from the Institut Pasteur de Tunis - معهد باستور تونس– gave insights on their ongoing research in the surveillance studies of emerging viruses in humans and insects.

We also had the pleasure of speaking with Tamara Giles-Vernick, Director of Research and Head of the Anthropology and Ecology of Disease Emergence- Institut Pasteur, who gave an overview on a key piece of the puzzle faced by UniHealth: the engagement, preparedness and response of the society to epidemics/pandemics.

Jan Felix Drexler, Prof. at the Institute of Virology - Charité - Universitätsmedizin Berlin unveiled the major aspect of the clinical evaluation of the specific viruses-assays with the devices using crude patients’ samples and animal specimens.

👉 Dive into the full series on our website to find out more: https://lnkd.in/d8qVirDA

This link will take you to a page that’s not on LinkedIn

17/03/2025

📌Workshop alert: ''Regulatory requirements for medical devices in digital health: Challenges and opportunities''.

Regulatory Compliance leading to the achievement of proper Regulatory Clearance and obtaining of the relevant Certification is currently the bottleneck for the rapid/efficient release of robust, accurate and safe medical devices and assays.
PKNM Solutions Sàrl, UniHealth regulatory expert partner defines the pathway for successful commercialization of the UniHealth products to EU target market and considers regulatory objectives, landscape, and characterizes risks assessment.

Aikaterini Zisaki, Quality & Regulatory Director at PKNM Solutions Sàrl Solutions will present a workshop breaking down the challenges and opportunities in this evolving space:
👉 Latest regulatory trends
👉 Certification pathways and compliance strategies
👉 Key considerations for digital health solutions

📅 Date: 18 March 2025 | 🕒 Time: 15:00 – 16:30 CET
📩Secure your spot: https://shorturl.at/9alGo

📌 Navigating the regulatory landscape for medical devices in the healthcare sector can be complex, but staying compliant is key to innovation and patient safety.

This form is designed to confirm your participation in a series of Online Workshops organised under the EVOLVE2CARE project, which aims to validate the needs of focal stakeholder groups and co-create with them Key Performance Indicators (KPIs) to enhance transitional healthcare services. The term, T...

06/02/2025

🔥 UniHealth EU will join the Spring school PREPARE-EU "Connecting European Expertise for Pandemic Preparedness", organized by KU Leuven in the framework of EU project PCR-4-ALL and Leuven One Health.

🧑‍🎓The spring school is aimed at graduate and PhD students as well as at post-doctoral researchers or other academic and industrial professionals working or interested in the broad variety of research fields related to pandemic preparedness.

📅 2-3 June 2025
➡️ More info and registration: https://lnkd.in/eJ6NTVvc
🔈 Check our fantastic line-up of speakers: https://lnkd.in/ehnz3JHu

This link will take you to a page that’s not on LinkedIn